Norepinephrine Signaling Through β-Adrenergic Receptors is Critical for Expression of Cocaine-Induced Anxiety

Biological Psychiatry

Volumn 63, Issue 11, 2008, Pages 1007-1012

  Schank, Jesse R ^a   Liles, L Cameron ^a   Weinshenker, David ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety; cocaine; disulfiram; dopamine hydroxylase; elevated plus maze; norepinephrine

Indexed keywords

BETA ADRENERGIC RECEPTOR; DISULFIRAM; DOPAMINE BETA MONOOXYGENASE; NORADRENALIN; PRAZOSIN; PROPRANOLOL; YOHIMBINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; C57BL MOUSE; COCAINE DEPENDENCE; CONTROLLED STUDY; ENZYME INHIBITION; EXPLORATORY BEHAVIOR; FEMALE; KNOCKOUT MOUSE; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; COCAINE; DISEASE MODELS, ANIMAL; DISULFIRAM; DOPAMINE BETA-HYDROXYLASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; MALE; MAZE LEARNING; MICE; MICE, KNOCKOUT; NOREPINEPHRINE; PROPRANOLOL; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION;

EID: 43049157802     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2007.10.018     Document Type: Article

References (36)

1. Ettenberg A., and Geist T.D. Animal model for investigating the anxiogenic effects of self-administered cocaine. Psychopharmacology (Berl) 103 (1991) 455-461
2. Rogireo R., and Takahashi R.N. Anxiogenic properties of cocaine in the rat evaluated with the elevated plus maze. Pharmacol Biochem Behav 43 (1992) 631-633
3. Yang X.-M., Gorman A.L., Dunn A.J., and Goeders N.E. Anxiogenic effects of acute and chronic cocaine administration: Neurochemical and behavioral studies. Pharmacol Biochem Behav 41 (1992) 643-650
4. Costall B., Kelly E., Naylor R.J., and Onaivi E.S. The actions of nicotine and cocaine in a mouse model of anxiety. Pharmacol Biochem Behav 33 (1988) 197-203
5. Blanchard D.C., and Blanchard R.J. Cocaine potentiates defensive behaviors related to fear and anxiety. Neurosci Biobehav Rev 23 (1999) 981-991
6. David V., Gold L.H., Koob G.F., and Cazala P. Anxiogenic-like effects limit rewarding effects of cocaine in BALB/cByJ Mice. Neuropsychopharmacology 24 (2001) 300-318
7. Paine T.A., Jackman S.L., and Olmstead M.C. Cocaine-induced anxiety: Alleviation by diazepam, but not buspirone, dimenhydrinate, or diphenhydramine. Behav Pharmacol 13 (2002) 511-523
8. Drouin C., Darracq L., Trovero F., Blanc G., Glowinski J., Cotecchia S., and Tassin J.-P. α1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J Neurosci 22 (2002) 2873-2884
9. Schank J.R., Puglisi-Allegra S., Ventura R., Alcaro A., Cole C.D., Liles L.C., et al. Dopamine β-hydroxylase knockout mice have alterations in dopamine signaling and are hypersensitive to cocaine-induced locomotion, reward, and aversion. Neuropsychopharmacology 31 (2006) 2221-2230
10. Ventura R., Cabib S., Alcaro A., Orsini C., and Puglisi-Allegra S. Norepinephrine in the prefrontal cortex is critical for amphetamine-induced reward and mesoaccumbens dopamine release. J Neurosci 23 (2003) 1879-1885
11. Weinshenker D., Miller N.S., Blizinsky K., Laughlin M.L., and Palmiter R.D. Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals. Proc Natl Acad Sci U S A 99 (2002) 13873-13877
12. Gorman A.L., and Dunn A.J. β-Adrenergic receptors are involved in stress-related behavioral changes. Pharmacol Biochem Behav 45 (1993) 1-7
13. Stanford S.C. Central noradrenergic neurons and stress. Pharmacol Ther 68 (1995) 297-342
14. Thomas S.A., Matsumoto A.M., and Palmiter R.D. Noradrenaline is essential for mouse fetal development. Nature 374 (1995) 643-646
15. Thomas S.A., Marck B.T., Palmiter R.D., and Matsumoto A.M. Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine β-hydroxylase. J Neurochem 70 (1998) 2468-2476
16. Bourdelat-Parks B.N., Anderson G.M., Donaldson Z.R., Weiss J.M., Bonsall R.W., Emery M.S., et al. Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice. Psychopharmacology (Berl) 183 (2005) 72-80
17. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
18. Johnston A.L., and File S.E. Yohimbine's anxiogenic action: Evidence for noradrenergic and dopaminergic sites. Pharmacol Biochem Behav 32 (1988) 151-156
19. Murchison C.F., Zhang X.Y., Zhang W.P., Ouyang M., Lee A., and Thomas S.A. A distinct role for norepinephrine in memory retrieval. Cell 117 (2004) 131-143
20. Maj J., Przegalinski E., and Wielosz M. Disulfiram and the drug-induced effects on motility. J Pharm Pharmacol 20 (1968) 247-248
21. Musacchio J.M., Goldstein M., Anagnoste B., Poch G., and Kopin I.J. Inhibition of dopamine-beta-hydroxylase by disulfiram in vivo. J Pharmacol Exp Ther 152 (1966) 56-61
22. Marino M.D., Bourdelat-Parks B.N., Liles L.C., and Weinshenker D. Genetic reduction of noradrenergic function alters social memory and reduces aggression in mice. Behav Brain Res 161 (2005) 197-203
23. Erb S., Hitchcott P.K., Rajabi H., Mueller D., Shaham Y., and Stewart J. Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology 23 (2000) 138-150
24. Shaham Y., Highfield D., Delfs J., Leung S., and Stewart J. Clonidine blocks stress-induced reinstatement of heroin seeking in rats: An effect independent of locus coeruleus noradrenergic neurons. Eur J Neurosci 12 (2000) 292-302
25. Leri F., Flores J., Rodaros D., and Stewart J. Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. J Neurosci 22 (2002) 5713-5718
26. Aston-Jones G., and Harris G.C. Brain substrates for increased drug seeking during protracted withdrawal. Neuropharmacology 47 suppl 1 (2004) 167-179
27. Morilak D.A., Barrera G., Echevarria D.J., Garcia A.S., Hernandez A., Ma S., and Petre C.O. Role of brain norepinephrine in the behavioral response to stress. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 1214-1224
28. Cubells J.F., Kranzler H.R., McCance-Katz E., Anderson G.M., Malison R.T., Price L.H., and Gelernter J. A haplotype at the DBH locus, associated with low plasma dopamine β-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry 5 (2000) 56-63
29. Kalayasiri R., Sughondhabirom A., Gueorguieva R., Coric V., Lynch W.J., Lappalainen J., et al. Dopamine beta-hydroxylase gene (DbetaH)-1021C→T influences self-reported paranoia during cocaine self-administration. Biol Psychiatry 61 (2007) 1310-1313
30. Darracq L., Blanc G., Glowinski J., and Tassin J.P. Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J Neurosci 18 (1998) 2729-2739
31. Sanders J.D., Szot P., Weinshenker D., Happe H.K., Bylund D.B., and Murrin L.C. Analysis of brain adrenergic receptors in dopamine β-hydroxylase knockout mice. Brain Res 1109 (2006) 45-53
32. Carroll K.M., Fenton L.R., Ball S.A., Nich C., Frankforter T.L., Shi J., and Rounsaville B.J. Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients. Arch Gen Psychiatry 61 (2004) 264-272
33. Kampman K.M., Volpicelli J.R., Mulvaney F., Alterman A.I., Cornish J., Gariti P., et al. Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity. Drug Alcohol Depend 63 (2001) 69-78
34. McDougle C.J., Black J.E., Malison R.T., Zimmermann R.C., Kosten T.R., Heninger G.R., and Price L.H. Noradrenergic dysregulation during discontinuation of cocaine use in addicts. Arch Gen Psychiatry 51 (1994) 713-719
35. Harris G.C., and Aston-Jones G. Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats. Psychopharmacology (Berl) 113 (1993) 131-136
36. Rudoy C.A., and Van Bockstaele E.J. Betaxolol, a selective β-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 1119-1129